Posts mit dem Label BNT162b2 vaccine from Pfizer/BioNTech werden angezeigt. Alle Posts anzeigen
Posts mit dem Label BNT162b2 vaccine from Pfizer/BioNTech werden angezeigt. Alle Posts anzeigen

Donnerstag, Juli 29, 2021

Pfizer: Pfizer-BioNTech COVID-19 Vaccine(also known as BNT162b2)

This product information is intended only for residents of the United States.This product is exclusively distributed within the U.S. under an Emergency Use Authorization from FDA.The Pfizer-BioNTech COVID-19 vaccine has not been approved or licensed by the U.S. Food and Drug Administration (FDA), but has been authorized for emergency use by FDA under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) for use in individuals 16 years of age and older. more...

Donnerstag, Juni 10, 2021

The BNT162b2 mRNA vaccine against SARS-CoV-2 reprograms both adaptive and innate immune response

The mRNA-based BNT162b2 vaccine from Pfizer/BioNTech was the first registered COVID-19 vaccine and has been shown to be up to 95% effective in preventing SARS-CoV-2 infections. Little is known about the broad effects of the new class of mRNA vaccines, especially whether they have combined effects on innate and adaptive immune responses. mehr...